Cancer Control — CFDA 93.399

Cancer-control obligations at $1.37 billion

USAspending.gov records $1,370,896,394.04 in obligations under CFDA 93.399. One hundred one awards produce that stock. A simple average is about $13,573,232 per award — consistent with multi-year research and control centers rather than small screening grants. That average is a quotient of two packet totals, not a typical study budget and not a cost per patient screened.

The assistance-listing title is CANCER CONTROL. CFDA 93.399 is the identifier. Other cancer research listings tagged under different CFDA numbers are not mixed into the $1.37 billion. Combining those codes would invent a combined NCI total this packet does not contain. Thirty-five jurisdictions appear in the geographic count, a narrower map than most HHS formula files. Outlays remain a separate column from the $1,370,896,394.04 obligation stock.

79 recipients on a 35-jurisdiction map

Seventy-nine recipients share 101 awards, or about 1.3 award records per recipient on average. Splitting $1,370,896,394.04 evenly would assign about $17.35 million per recipient. That density is a research-center pattern. The packet does not list the 79. Recipient count is the organizational headcount on the federal extract, not a census of cancer centers, clinics, or investigators.

Thirty-five jurisdictions in the geographic count is a tighter map than many HHS formula listings. Cancer-control dollars still follow awarded institutions, not equal shares. Place-of-performance amounts are on the program table.

Award count is not a trial or patient count

Among HHS research listings, 93.399 is a concentrated file: 101 rows against 79 recipients. Award count is a weak proxy for “number of cancer-control studies” and a worse proxy for patients. Recipients (79) tell you how many named organizations sit on the extract; awards (101) tell you how many assistance rows were stored.

The packet does not report screening rates, mortality, or publications. Citing 101 as trials or 79 as cancer centers would be a unit error. Keep the units straight: dollars, awards, recipients, jurisdictions.

Obligations versus cancer-control outlays

The $1,370,896,394.04 is an obligation total from USAspending.gov. Outlays — cash paid against Cancer Control awards — are not in the packet. A research file can show a large obligation stock while annual draws follow a later calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.399 to size this cancer-control listing in the assistance file. Do not use it as an incidence dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.399.

What the 93.399 tables omit

The program hub lists award-backed obligations from USAspending.gov. It is not a patient registry, not a trial catalog, and not a mortality table. Series that never appear as assistance awards will not show up in the $1,370,896,394.04. That omission is definitional rather than a gap in the 101 award rows.

Place-of-performance on 35 jurisdictions is a coding field. Read the program page before treating those cells as the full cancer-burden map. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already paid to institutions.

A researcher comparing 93.399 with other cancer research codes should keep CFDA numbers separate. Thirty-five jurisdictions is a place-of-performance count, not a cancer-burden map.

Where the 93.399 table lives

The program page overlays these four facts. The all-programs index ranks 93.399 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.399 only, start on the program page.

CFDA 93.399’s 101 awards spread $1,370,896,394.04 across 79 recipients and 35 jurisdictions. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 1.3 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

Cancer Control is a concentrated research listing: 101 awards, 79 recipients, 35 jurisdictions, about $13.6 million per award. That structure is the fingerprint, not a trial or patient census. Read the $1,370,896,394.04 as the USAspending obligation stock for CFDA 93.399 only.

Questions

How much is obligated for Cancer Control?

USAspending.gov records $1,370,896,394.04 in obligations for CFDA 93.399. SpendingVault indexes 101 awards, 79 recipients, and 35 jurisdictions. The figure is an obligation sum from assistance awards, not an outlay and not a patient or trial count. CFDA 93.399’s $1.37 billion is the USAspending obligation stock.

How many awards does CFDA 93.399 carry?

The listing shows 101 awards against 79 recipients, or about 1.3 award records per recipient. A simple average is about $13,573,232 per award. Award count is not a count of clinical trials. Recipient dollars are on the program page.

How many organizations receive 93.399 awards?

The extract lists 79 recipients. Those are organizational recipients on assistance awards tagged 93.399, not a census of cancer centers. Geographic coding covers 35 jurisdictions. The packet does not name the 79 or publish screening volumes.

Is $1.37 billion already paid for cancer-control work?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.399’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or patients screened. The $1,370,896,394.04 on 101 awards is the obligation figure.